BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19181000)

  • 1. The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration.
    Philippou A; Maridaki M; Koutsilieris M
    In Vivo; 2008; 22(6):735-50. PubMed ID: 19181000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
    Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury.
    Shen W; Li Y; Zhu J; Schwendener R; Huard J
    J Cell Physiol; 2008 Feb; 214(2):405-12. PubMed ID: 17657727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.
    Tkachuk VA; Plekhanova OS; Parfyonova YV
    Can J Physiol Pharmacol; 2009 Apr; 87(4):231-51. PubMed ID: 19370078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local activation of TGF-beta1 at endometriosis sites.
    Komiyama S; Aoki D; Komiyama M; Nozawa S
    J Reprod Med; 2007 Apr; 52(4):306-12. PubMed ID: 17506371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.
    Lluís F; Roma J; Suelves M; Parra M; Aniorte G; Gallardo E; Illa I; Rodríguez L; Hughes SM; Carmeliet P; Roig M; Muñoz-Cánoves P
    Blood; 2001 Mar; 97(6):1703-11. PubMed ID: 11238111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle regeneration: cellular and molecular events.
    Karalaki M; Fili S; Philippou A; Koutsilieris M
    In Vivo; 2009; 23(5):779-96. PubMed ID: 19779115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for tissue regeneration.
    Cutroneo KR
    J Cell Biochem; 2003 Feb; 88(2):418-25. PubMed ID: 12520545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasmin system in airway remodeling.
    Kucharewicz I; Kowal K; Buczko W; Bodzenta-Łukaszyk A
    Thromb Res; 2003; 112(1-2):1-7. PubMed ID: 15013265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
    Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
    Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin, substilisin-like endoproteases, tissue plasminogen activator, and urokinase plasminogen activator are involved in activation of latent TGF-beta 1 in human seminal plasma.
    Chu TM; Kawinski E
    Biochem Biophys Res Commun; 1998 Dec; 253(1):128-34. PubMed ID: 9875232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy.
    Salvadori C; Peters IR; Day MJ; Engvall E; Shelton GD
    Muscle Nerve; 2005 Feb; 31(2):192-8. PubMed ID: 15736299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TGF-β1 during skeletal muscle regeneration.
    Delaney K; Kasprzycka P; Ciemerych MA; Zimowska M
    Cell Biol Int; 2017 Jul; 41(7):706-715. PubMed ID: 28035727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).
    Suelves M; Vidal B; Ruiz V; Baeza-Raja B; Diaz-Ramos A; Cuartas I; Lluis F; Parra M; Jardi M; Lopez-Alemany R; Serrano AL; Munoz-Canoves P
    Front Biosci; 2005 Sep; 10():2978-85. PubMed ID: 15970552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma interferon as an antifibrosis agent in skeletal muscle.
    Foster W; Li Y; Usas A; Somogyi G; Huard J
    J Orthop Res; 2003 Sep; 21(5):798-804. PubMed ID: 12919866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration.
    Bryer SC; Fantuzzi G; Van Rooijen N; Koh TJ
    J Immunol; 2008 Jan; 180(2):1179-88. PubMed ID: 18178858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of latent transforming growth factor beta1 by Mycobacterium tuberculosis in human mononuclear phagocytes.
    Aung H; Wu M; Johnson JL; Hirsch CS; Toossi Z
    Scand J Immunol; 2005 Jun; 61(6):558-65. PubMed ID: 15963051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.
    Naruse K; Lash GE; Bulmer JN; Innes BA; Otun HA; Searle RF; Robson SC
    Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro flexor tendon cell response to TGF-beta1: a gene expression study.
    Klass BR; Rolfe KJ; Grobbelaar AO
    J Hand Surg Am; 2009 Mar; 34(3):495-503. PubMed ID: 19258148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.